Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Plx Pharma Inc's Business Segments
Plx Pharma Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 0
Regions Reported
-
Plx Pharma Inc does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue by Product & Service Category - FY
- Vazalore0%
- Product100%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Vazalore | $ 0 | - |
| Product | $ 0 | 100% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Plx Pharma Inc
PLx Pharma Inc is a pharmaceutical company that specializes in developing innovative and differentiated products to improve patient outcomes. The company's primary focus lies in the development and commercialization of a novel dosage form known as PLxGuard.
PLx Pharma's flagship product, PLxGuard, is an innovative oral formulation of aspirin, a commonly used medication for pain relief, reducing inflammation, and preventing blood clots. PLxGuard offers several advantages over traditional aspirin, including a more rapid and predictable absorption, improved safety profile, and reduced risk of gastrointestinal bleeding.
The unique design of PLxGuard involves the use of solubilized liquid-filled capsules, which release aspirin directly in the small intestine instead of the stomach. This targeted delivery mechanism avoids direct contact with the gastric mucosa, reducing the risk of irritation and bleeding in the stomach. Moreover, the liquid-filled capsules ensure faster and more consistent absorption of aspirin, leading to a more rapid onset of action.
PLx Pharma has conducted extensive clinical trials to demonstrate the efficacy, safety, and benefit of PLxGuard compared to traditional aspirin formulations. These trials have shown that PLxGuard achieves its therapeutic effect more quickly, resulting in better pain relief and inflammation reduction. Additionally, PLxGuard has been proven to reduce the risk of gastrointestinal bleeding by up to 65% compared to enteric-coated aspirin.
The company's commitment to driving innovation in the pharmaceutical industry extends beyond developing PLxGuard. PLx Pharma also engages in research and development activities to expand its portfolio of differentiated products. The company utilizes advanced technologies and formulation expertise to create improved drug delivery systems, enhancing patient experience and therapeutic outcomes.
In addition to product development, PLx Pharma focuses on ensuring the successful commercialization of its products. The company works closely with healthcare professionals, patients, and payers to raise awareness about the benefits of PLxGuard and facilitate patient access to this innovative medication. PLx Pharma maintains strategic partnerships with distributors and other healthcare organizations to reach a wide range of markets globally.
PLx Pharma Inc operates in a highly regulated industry and adheres to strict quality standards in all aspects of its operations. The company prioritizes patient safety, clinical excellence, and scientific rigor in its development processes, seeking FDA approvals and other regulatory clearances to bring its products to market.
Overall, PLx Pharma Inc is a forward-thinking pharmaceutical company that aims to revolutionize drug delivery and improve patient outcomes through its innovative PLxGuard formulation. With a strong commitment to innovation, clinical excellence, and patient safety, PLx Pharma strives to make a lasting impact in the pharmaceutical industry.
PLx Pharma's flagship product, PLxGuard, is an innovative oral formulation of aspirin, a commonly used medication for pain relief, reducing inflammation, and preventing blood clots. PLxGuard offers several advantages over traditional aspirin, including a more rapid and predictable absorption, improved safety profile, and reduced risk of gastrointestinal bleeding.
The unique design of PLxGuard involves the use of solubilized liquid-filled capsules, which release aspirin directly in the small intestine instead of the stomach. This targeted delivery mechanism avoids direct contact with the gastric mucosa, reducing the risk of irritation and bleeding in the stomach. Moreover, the liquid-filled capsules ensure faster and more consistent absorption of aspirin, leading to a more rapid onset of action.
PLx Pharma has conducted extensive clinical trials to demonstrate the efficacy, safety, and benefit of PLxGuard compared to traditional aspirin formulations. These trials have shown that PLxGuard achieves its therapeutic effect more quickly, resulting in better pain relief and inflammation reduction. Additionally, PLxGuard has been proven to reduce the risk of gastrointestinal bleeding by up to 65% compared to enteric-coated aspirin.
The company's commitment to driving innovation in the pharmaceutical industry extends beyond developing PLxGuard. PLx Pharma also engages in research and development activities to expand its portfolio of differentiated products. The company utilizes advanced technologies and formulation expertise to create improved drug delivery systems, enhancing patient experience and therapeutic outcomes.
In addition to product development, PLx Pharma focuses on ensuring the successful commercialization of its products. The company works closely with healthcare professionals, patients, and payers to raise awareness about the benefits of PLxGuard and facilitate patient access to this innovative medication. PLx Pharma maintains strategic partnerships with distributors and other healthcare organizations to reach a wide range of markets globally.
PLx Pharma Inc operates in a highly regulated industry and adheres to strict quality standards in all aspects of its operations. The company prioritizes patient safety, clinical excellence, and scientific rigor in its development processes, seeking FDA approvals and other regulatory clearances to bring its products to market.
Overall, PLx Pharma Inc is a forward-thinking pharmaceutical company that aims to revolutionize drug delivery and improve patient outcomes through its innovative PLxGuard formulation. With a strong commitment to innovation, clinical excellence, and patient safety, PLx Pharma strives to make a lasting impact in the pharmaceutical industry.
Plx Pharma Inc. also known as PLx Pharma, is a specialty pharmaceutical company focused on the development and commercialization of innovative drug delivery systems. The company primarily aims to enhance the safety and efficacy of existing medications through its proprietary technologies.
Segments
1. Pharmaceuticals
- PLx Pharma operates primarily in the pharmaceuticals segment, developing drugs that improve patient outcomes, especially for conditions that require long-term therapy.
2. Biotechnology
- The company is involved in biotechnology through the development of complex formulations that utilize biological and biochemical principles in their drug delivery systems.
Products
PLx Pharma’s product portfolio primarily focuses on non-opioid pain management solutions and gastrointestinal therapies. Some of the notable products include:
1. PLxs proprietary formulations:
- PLxGuard™ Technology: This is a patented drug delivery platform designed to provide a safer, more effective way to administer nonsteroidal anti-inflammatory drugs (NSAIDs). This technology aims to reduce gastrointestinal side effects typically associated with conventional NSAIDs.
- PaxVax™ To BioE: A collaboration-based product aimed at providing a novel delivery system for vaccines and other biologics.
- Dosing Strategies: The use of enhanced formulations for pain management that minimize risks associated with traditional delivery methods.
2. Prescription Products
- PLx Pharma has worked on formulating and testing products focused on mitigating risks related to gastrointestinal injuries from NSAIDs, which are overly prevalent in the chronic pain patient population.
- Their products are often centered around existing medications but re-engineered to improve safety profiles and efficacy.
3. Over-the-Counter (OTC) Products
- While primarily engaged in prescription products, PLx Pharma also explores opportunities in the OTC segment, looking to provide broader access to safer pain management alternatives.
Services
PLx Pharma Inc. provides several services related to pharmaceutical development, including:
1. Clinical Trials Management:
- The company undertakes the management of clinical trials for the testing of its formulations. This involves extensive planning, execution, and reporting of clinical findings to ensure that products meet safety and efficacy standards.
2. Regulatory Affairs Consulting:
- The company navigates the complex regulatory landscape associated with pharmaceutical development, assisting in the preparation and submission of regulatory documents to agencies such as the FDA. This includes the ability to guide products through various stages of development, including IND (Investigational New Drug) applications and NDA (New Drug Application) submissions.
3. Commercialization Strategies:
- Once products reach the market, PLx Pharma may assist in developing marketing strategies and partnership frameworks while ensuring compliance with industry regulations.
4. Research and Development Collaboration:
- PLx Pharma actively pursues collaborations with academic institutions and other biopharmaceutical companies to enhance and expand its product offerings through innovative research.
Strategic Focus
PLx Pharma’s strategic focus is on addressing unmet medical needs in pain management and gastrointestinal therapies. By leveraging its proprietary drug delivery technologies, the company strives to enhance the therapeutic index of existing drugs, ensuring that patients receive effective treatments with reduced adverse effects.
In summary, PLx Pharma Inc. is dedicated to developing advanced drug delivery systems that improve the safety and efficacy of pain management therapies, contributing significantly to the landscape of specialized pharmaceuticals. The ongoing innovation in their product development, alongside their commitment to regulatory excellence and commercial viability, positions them as a key player in the pharmaceutical industry.
Segments
1. Pharmaceuticals
- PLx Pharma operates primarily in the pharmaceuticals segment, developing drugs that improve patient outcomes, especially for conditions that require long-term therapy.
2. Biotechnology
- The company is involved in biotechnology through the development of complex formulations that utilize biological and biochemical principles in their drug delivery systems.
Products
PLx Pharma’s product portfolio primarily focuses on non-opioid pain management solutions and gastrointestinal therapies. Some of the notable products include:
1. PLxs proprietary formulations:
- PLxGuard™ Technology: This is a patented drug delivery platform designed to provide a safer, more effective way to administer nonsteroidal anti-inflammatory drugs (NSAIDs). This technology aims to reduce gastrointestinal side effects typically associated with conventional NSAIDs.
- PaxVax™ To BioE: A collaboration-based product aimed at providing a novel delivery system for vaccines and other biologics.
- Dosing Strategies: The use of enhanced formulations for pain management that minimize risks associated with traditional delivery methods.
2. Prescription Products
- PLx Pharma has worked on formulating and testing products focused on mitigating risks related to gastrointestinal injuries from NSAIDs, which are overly prevalent in the chronic pain patient population.
- Their products are often centered around existing medications but re-engineered to improve safety profiles and efficacy.
3. Over-the-Counter (OTC) Products
- While primarily engaged in prescription products, PLx Pharma also explores opportunities in the OTC segment, looking to provide broader access to safer pain management alternatives.
Services
PLx Pharma Inc. provides several services related to pharmaceutical development, including:
1. Clinical Trials Management:
- The company undertakes the management of clinical trials for the testing of its formulations. This involves extensive planning, execution, and reporting of clinical findings to ensure that products meet safety and efficacy standards.
2. Regulatory Affairs Consulting:
- The company navigates the complex regulatory landscape associated with pharmaceutical development, assisting in the preparation and submission of regulatory documents to agencies such as the FDA. This includes the ability to guide products through various stages of development, including IND (Investigational New Drug) applications and NDA (New Drug Application) submissions.
3. Commercialization Strategies:
- Once products reach the market, PLx Pharma may assist in developing marketing strategies and partnership frameworks while ensuring compliance with industry regulations.
4. Research and Development Collaboration:
- PLx Pharma actively pursues collaborations with academic institutions and other biopharmaceutical companies to enhance and expand its product offerings through innovative research.
Strategic Focus
PLx Pharma’s strategic focus is on addressing unmet medical needs in pain management and gastrointestinal therapies. By leveraging its proprietary drug delivery technologies, the company strives to enhance the therapeutic index of existing drugs, ensuring that patients receive effective treatments with reduced adverse effects.
In summary, PLx Pharma Inc. is dedicated to developing advanced drug delivery systems that improve the safety and efficacy of pain management therapies, contributing significantly to the landscape of specialized pharmaceuticals. The ongoing innovation in their product development, alongside their commitment to regulatory excellence and commercial viability, positions them as a key player in the pharmaceutical industry.